SGMOQ · Sangamo Therapeutics, Inc
$0.16
+0.01 (+4.63%)
At close · Aug 28
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“There is substantial doubt about our ability to continue to operate as a going concern. We will need substantial additional funding in the very near term to execute our operating plan and to continue to operate as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$66.29M
Shares
414.29M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-31 | 4,083 | $0.07 | $286 |
| 2026-07-29 | 93 | $0.07 | $7 |
| 2026-07-27 | 5,220 | $0.07 | $365 |
| 2026-07-24 | 6,952 | $0.07 | $487 |
| 2026-07-17 | 8,351 | $0.07 | $585 |
| 2026-07-16 | 5,245 | $0.07 | $367 |
| 2026-07-13 | 6,157 | $0.10 | $616 |
| 2026-07-10 | 5,629 | $0.08 | $450 |
| 2026-07-08 | 1 | $0.07 | $0 |
| 2026-07-06 | 5,720 | $0.07 | $400 |
| 2026-07-02 | 1,078,886 | $0.06 | $64,733 |
| 2026-07-01 | 765,914 | $0.05 | $38,296 |
| 2026-06-30 | 2,276 | $0.05 | $114 |
| 2026-06-26 | 170,000 | $0.04 | $6,800 |
Showing 1–14 of 14 settlements